June 25, 2015 / 8:31 PM / in 2 years

Valeant offers to buy Zoetis - WSJ

June 25 (Reuters) - Canada-based drugmaker Valeant Pharmaceuticals International Inc has approached to buy Zoetis Inc, an animal-health company, the Wall Street Journal reported.

Zoetis, spun off from Pfizer Inc in 2013, was valued at $24.85 billion as of Thursday’s close, according to Thomson Reuters data.

It was not clear what Zoetis's reaction to the approach was, if any, or whether it was open to a sale, the Journal reported, citing people familiar with the matter. (on.wsj.com/1fGK2qC)

Valeant spokeswoman Laurie Little declined to comment. Zoetis was not immediately available for comment. (Reporting by Rosmi Shaji in Bengaluru; Editing by Joyjeet Das)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below